EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information

Human medicines European public assessment report (EPAR): Lumykras, sotorasib, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Lumykras, sotorasib, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised

Orphan designation: Human monoclonal IgG1 antibody against tissue factor pathway inhibitor Treatment of haemophilia A, 14/10/2016 Withdrawn

Orphan designation: Human monoclonal IgG1 antibody against tissue factor pathway inhibitor Treatment of haemophilia A, 14/10/2016 Withdrawn

Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.